PUBLICATION

The Anti-Tumoral Potential of Phosphonate Analog of Sulforaphane in Zebrafish Xenograft Model

Authors
Rudzinska-Radecka, M., Janczewski, Ł., Gajda, A., Godlewska, M., Chmielewska-Krzesinska, M., Wasowicz, K., Podlasz, P.
ID
ZDB-PUB-211129-64
Date
2021
Source
Cells   10(11): (Journal)
Registered Authors
Podlasz, Piotr, Wasowicz, Krzysztof
Keywords
breast cancer, cervical cancer, glioblastoma, isothiocyanates, toxicology, zebrafish, zebrafish xenograft model
MeSH Terms
  • Animals
  • Antineoplastic Agents/pharmacology*
  • Cell Line, Tumor
  • Embryo, Nonmammalian/drug effects
  • Embryo, Nonmammalian/metabolism
  • Humans
  • Isothiocyanates/chemical synthesis
  • Isothiocyanates/chemistry
  • Isothiocyanates/pharmacology*
  • Microwaves
  • Organophosphonates/chemical synthesis
  • Organophosphonates/chemistry
  • Organophosphonates/pharmacology*
  • Signal Transduction/drug effects
  • Sulfoxides/chemical synthesis
  • Sulfoxides/chemistry
  • Sulfoxides/pharmacology*
  • Xenograft Model Antitumor Assays*
  • Zebrafish/embryology
  • Zebrafish/physiology*
PubMed
34831440 Full text @ Cells
Abstract
Isothiocyanates (ITCs) show strong activity against numerous human tumors. Five structurally diverse ITCs were tested in vivo using the zebrafish embryos 6 and 48 h post-fertilization (hpf). The survival rate, hatching time, and gross morphological changes were assessed 24, 48, and 72 h after treatment with all compounds in various doses (1-10 µM). As a result, we selected a phosphonate analog of sulforaphane (P-ITC; 1-3 µM) as a non-toxic treatment for zebrafish embryos, both 6 and 48 hpf. Furthermore, the in vivo anti-cancerogenic studies with selected 3 µM P-ITC were performed using a set of cell lines derived from the brain (U87), cervical (HeLa), and breast (MDA-MB-231) tumors. For the experiment, cells were labeled using red fluorescence dye Dil (1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindocarbocyanine, 10 μg/mL) and injected into the hindbrain ventricle, yolk sac region and Cuvier duct of zebrafish embryos. The tumor size measurement after 48 h of treatment demonstrated the significant inhibition of cancer cell growth in all tested cases by P-ITC compared to the non-treated controls. Our studies provided evidence for P-ITC anti-cancerogenic properties with versatile activity against different cancer types. Additionally, P-ITC demonstrated the safety of use in the living organism at various stages of embryogenesis.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping